BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2737629
Number of visits today
715
Number of downloads
2008993
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Arteaga Cabeza O, Mikrogeorgiou A, Kannan S, Ferriero DM. Advanced nanotherapies to promote neuroregeneration in the injured newborn brain. Adv Drug Deliv Rev 2019;148:19-37. [PMID: 31678359 DOI: 10.1016/j.addr.2019.10.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Metallinou D, Lazarou E, Lykeridou A. Pharmacological and Non-Pharmacological Brain-Focused Clinical Practices for Premature Neonates at High Risk of Neuronal Injury. Maedica (Bucur) 2021;16:281-90. [PMID: 34621352 DOI: 10.26574/maedica.2020.16.2.281] [Reference Citation Analysis]
2 Narayanamurthy R, Yang JJ, Yager JY, Unsworth LD. Drug delivery platforms for neonatal brain injury. J Control Release 2021;330:765-87. [PMID: 33417984 DOI: 10.1016/j.jconrel.2020.12.056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Zhou W, Fu Y, Zhang M, Buabeid MA, Ijaz M, Murtaza G. Nanoparticle-mediated therapy of neuronal damage in the neonatal brain. Journal of Drug Delivery Science and Technology 2021;61:102208. [DOI: 10.1016/j.jddst.2020.102208] [Reference Citation Analysis]
4 Arteaga Cabeza O, Zhang Z, Smith Khoury E, Sheldon RA, Sharma A, Zhang F, Slusher BS, Kannan RM, Kannan S, Ferriero DM. Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury. Neurobiol Dis 2021;148:105201. [PMID: 33271328 DOI: 10.1016/j.nbd.2020.105201] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Basargina MA, Fisenko AP, Bombardirova EP, Smirnov IE, Kharitonova NA, Illarionova MS. MODELING OF THE SANOGENETIC DEVELOPING ENVIRONMENT AND STARTING NON-DRUG HABILITATION OF PREMATURE INFANTS. RPJ 2019;22:380-387. [DOI: 10.18821/1560-9561-2019-22-6-380-387] [Reference Citation Analysis]
6 Lowe TL, Agrahari V, Kannan RM, Kannan S. Nanotechnology enabled regenerative medicine for neurological disorders. Adv Drug Deliv Rev 2019;148:1-2. [PMID: 31787167 DOI: 10.1016/j.addr.2019.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345